Blog
Top Research Reports for UnitedHealth, BlackRock & Salesforce
Monday, June 29, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth
Buy, Hold, or Sell Micron (MU) Stock After Its Record Q3 Results?
Micron Technology MU) delivered another blockbuster quarterly report last week, underscoring why the memory-chip maker has become one of the biggest beneficiaries of the artificial intelligence
Are Options Traders Betting on a Big Move in Mettler-Toledo Stock?
Investors in Mettler-Toledo International Inc. MTD need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $1450 Call had some of the
Implied Volatility Surging for Seadrill Stock Options
Investors in Seadrill Limited SDRL need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 18, 2026 $17.50 Call had some of the highest implied
IONQ vs. QUBT: Which Quantum Stock is Poised for More Upside in July?
Quantum-computing stocks endured a difficult June as persistent inflation, a higher-for-longer interest-rate environment and investor anxiety following the latest debate surrounding Microsoft's
3 AI Infrastructure Stocks Up 500%+ With More Upside in 2H 2026
For investors seeking outsized returns heading into the second half of the year, they should focus on high-momentum stocks, following Richard Driehaus’s renowned “buy high and sell higher” strategy
Top Stock Picks for Week of June 29, 2026
Micron Technology (MU) has established itself as one of the leading worldwide providers of semiconductor memory solutions.Micron is benefiting from the rapidly expanding artificial intelligence
3 Reasons Investors Should Buy in July
First Pullback to 50-day Moving Average
On Wall Street, even the strongest uptrends and bull markets eventually succumb to gravity and must pullback. Rather than chasing highs like most retail
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
Harmony Biosciences Holdings, Inc. HRMY sits at an interesting point for investors. The stock looks inexpensive by several valuation measures, but the company depends heavily on Wakix for revenues.
HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase
Harmony Biosciences Holdings, Inc. HRMY is no longer only a Wakix revenue story. The company is using its sleep-wake franchise to fund a broader neuroscience strategy.
The central question is
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
Harmony Biosciences Holdings, Inc. HRMY is trying to turn a successful narcolepsy franchise into a broader neuroscience platform.
The transition is funded by Wakix, which still does most of the
Real Estate ETF (AVRE) Touches a New 52-Week High
For investors seeking momentum, Avantis Real Estate ETF AVRE is probably on the radar now. The fund just hit a 52-week high and jumped 12.7% from its 52-week low price of $42.98 per share.
But are
Energy ETFs to Buy as Oil Price Slides to Pre-Iran War Level
The global energy market has experienced a dramatic round-trip. Following a joint U.S.-Israel strike on Iran in late February 2026 and the consequent closure of the Strait of Hormuz, which disrupted
Can Duke Energy's Investment Plan Deliver Years of Earnings Growth?
Duke Energy DUK is entering one of the largest capital investment cycles in its history, positioning itself to benefit from rising electricity demand while maintaining relatively predictable cash
Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?
Encompass Health Corporation EHC has reached an interesting point in its growth story. Demand is no longer the primary metric to watch. Supported by an aging U.S. population, the need for inpatient
Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?
Intuitive Surgical’s ISRG long-term competitive advantage increasingly rests on its “Quintuple Aim” strategy, a framework centered on delivering better clinical outcomes, improved patient
Can Carter's Brand Strength and Omnichannel Strategy Sustain Growth?
Carter's, Inc. CRI continues to leverage its well-established brands to drive customer demand. The company is investing in product innovation, expanding assortments and introducing trend-right
Why HF Sinclair Is a Cash Flow Story, Not Merely a Valuation Play
HF Sinclair Corporation’s DINO investment appeal leans primarily on its ability to turn refining strength into cash while trading at a discounted valuation.
The stock trades at a cheaper forward
Cameco's Adjusted EBITDA Up 44% in Q126: More Upside Ahead?
Cameco Corporation’s CCJ adjusted EBITDA has shown a strong and sustained upward trajectory over the past few years, driven primarily by uranium price strength and contributions from Westinghouse.
HF Sinclair's Multiple Growth Levers Strengthen Its Investment Case
HF Sinclair Corporation DINO benefits from several downstream trends shaping energy markets in 2026: tighter regional fuel supplies, resilient distillate demand, improving renewable diesel economics
Here's Why You Should Retain Powell Industries in Your Portfolio
Powell Industries, Inc.’s POWL robust momentum can be largely attributed to its strong foothold and strength in several key markets, including oil and gas, electric utility, and commercial & other





